A new analysis found use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) is associated with increased mortality rates; the Government Accountability Office (GAO) appointed a new chair of the Medicare Payment Advisory Commission (MedPAC); nearly 80% of Americans live in counties where COVID-19 is spreading widely.
Use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among patients hospitalized with coronavirus disease 2019 (COVID-19), according to a multinational registry analysis published in The Lancet. The study included data from nearly 15,000 patients who took the drugs with or without antibiotics azithromycin or clarithromycin and 81,000 controls. Study authors urge the regimens should only be used by patients with COVID-19 enrolled in clinical trials. President Donald Trump announced earlier this week he was taking hydroxychloroquine regularly despite testing negative for COVID-19. Previous research found use of hydroxychloroquine and azithromycin can lead to serious heart problems.
The Government Accountability Office (GAO) announced Michael Chernew, PhD, as the newly appointed chair of the Medicare Payment Advisory Commission (MedPAC). Additional new appointees to MedPAC include Betty Rambur, PhD, RN, FAAN, and Wayne J. Riley, MD. MedPAC was founded in 1997 to analyze access to care, costs, quality of care, and other important issues affecting Medicare. It also advises Congress on payments to health plans in the Medicare Advantage program and to providers in Medicare’s fee-for-service programs. Chernew serves as the Leonard D. Schaffer Professor of Health Care Policy at Harvard Medical School, is co-editor-in-chief of The American Journal of Managed Care®, and is a member of the National Bureau of Economic Research, the National Academy of Sciences, and the National Academy of Social Insurance.
A Brookings Institution analysis found that nearly 80% of Americans now live in counties where COVID-19 is spreading widely, The Hill reports. Virus outbreaks in Southern and Midwestern states mark an epicenter shift away from New York City and other highly populated areas affected early on. The report found that 176 counties have begun to see substantial spread of the virus within the last week. The majority, 156, are smaller, rural counties. However, more populated cities like Tampa and St. Petersburg, Florida, are now reporting dozens of new cases, while Collin County, Texas, and Wake County, North Carolina, exhibit signs of broader spread. The report also documents spread in exurban areas outside of major cities like Minneapolis, Milwaukee, and Columbus, Ohio.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More